Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20739054 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag
Condition: Purpura, Thrombocytopenic, Idiopathic
Interventions: Drug: eltrombopag;   Drug: Placebo

Indicates status has not been verified in more than two years